FDA OKs Nonprescription Use of Johnson & Johnson’s Zyrtec-D

WASHINGTON, Nov 9 (Reuters) - The U.S. Food and Drug Administration on Friday approved the nonprescription use of Zyrtec-D, an allergy drug made by Johnson & Johnson’s (JNJ.N: Quote, Profile, Research) McNeil unit, for adults and children 12 years or older.

MORE ON THIS TOPIC